about omics group

39
About OMICS Group OMICS Group International is an amalgamation of Open Access publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology ‘Open Access’, OMICS Group publishes 400 online open access scholarly journals in all aspects of Science, Engineering, Management and Technology journals. OMICS Group has been instrumental in taking the knowledge on Science & technology to the doorsteps of ordinary men and women. Research Scholars, Students, Libraries, Educational Institutions, Research centers and the industry are main stakeholders that benefitted greatly from this knowledge dissemination. OMICS Group also organizes 300 International conferences annually across the globe, where knowledge transfer takes

Upload: milton

Post on 05-Jan-2016

35 views

Category:

Documents


3 download

DESCRIPTION

About OMICS Group. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: About OMICS Group

About OMICS Group

OMICS Group International is an amalgamation of Open Access publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology ‘Open Access’, OMICS Group publishes 400 online open access scholarly journals in all aspects of Science, Engineering, Management and Technology journals. OMICS Group has been instrumental in taking the knowledge on Science & technology to the doorsteps of ordinary men and women. Research Scholars, Students, Libraries, Educational Institutions, Research centers and the industry are main stakeholders that benefitted greatly from this knowledge dissemination. OMICS Group also organizes 300 International conferences annually across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions.

Page 2: About OMICS Group

About OMICS Group Conferences

OMICS Group International is a pioneer and leading science event organizer, which publishes around 400 open access journals and conducts over 300 Medical, Clinical, Engineering, Life Sciences, Phrama scientific conferences all over the globe annually with the support of more than 1000 scientific associations and 30,000 editorial board members and 3.5 million followers to its credit.

OMICS Group has organized 500 conferences, workshops and national symposiums across the major cities including San Francisco, Las Vegas, San Antonio, Omaha, Orlando, Raleigh, Santa Clara, Chicago, Philadelphia, Baltimore, United Kingdom, Valencia, Dubai, Beijing, Hyderabad, Bengaluru and Mumbai.

Page 3: About OMICS Group

黃耆六一湯之免疫調節評估Immunomodulatory Effects of

Huang Qi Liu Yi Tang

黃冠誠醫師Assist. Prof. Guan-Cheng

Huang M.D.台灣。高雄。阮綜合醫院

3

Page 4: About OMICS Group

4

出典:太平惠民和劑局方 組成:黃耆 67.5, 甘草 11.25, 大棗 11.25 克 效用:諸虛不足

Radix Astragali Licorice Jujube

黃耆六一湯 Huang Qi Liu Yi Tang (HQLYT)

Page 5: About OMICS Group

治諸虛不足

增強免疫力

5

Page 6: About OMICS Group

黃耆六一湯之主要藥材黃耆

產地甘肅、陜西、蒙古、河北、

山西等 性味

甘,微溫 效用

補氣升陽,益衛固表,托瘡生肌,利水消腫。

6

台灣習用品 - 晉耆

北耆

Page 7: About OMICS Group

本草記載• 神農本草經

– 主癰疽,久敗瘡… . 小兒百病。• 本經逢源

– 能補五臟諸虛,… . 無汗則發,有汗則止,入肺而固表虛自汗,入脾而托已潰癰。

• 本草求真– 黃耆,入肺補氣,入表實衛,為補氣諸藥之最,是

以有耆之稱。 • 本草備要

– 黃耆“生血、生肌、排膿內托,瘡癰聖藥”。7

Page 8: About OMICS Group

黃耆之主要成分7,3’-dihydroxy-4’-methoxyisoflavone 7-O- -D-glucoside

formononetin 7-O--D-glucoside

(6RR,11RR)-3-hydroxy-9,10-dimethoxypterocarpan 3-O--D-glucoside

7,2’-dihydroxy-3’,4’-dimethoxyisoflavan 7-O--D-glucoside

7,3’-dihydroxy-4’-methoxyisoflavone

8

Page 9: About OMICS Group

9

Page 10: About OMICS Group

Quality Control of Hedysarum polybotrys extracts

Hedysarum polybotrys

Hot water (H) MeOH (M)

H2O layer(M-H)

EtOAc layer(M-EA)

Partition

10

H. polybotrys

Quality control

Yield

(%)

Proanthocyanidina

(mg/g)

Formononetinb

(mg/g)

H 33.70 2.60 13.45 ±1.79

M 15.16 7.68 208.36 ±1.69

M-H 14.41 3.75 ND

M-EA 0.75 36.14 5457.05 ± 174.02

a Total proanthocyanidin was expressed as mg of catechin equivalents per g of extract.b Formononetin was a substance marker for H. polybotrys.

晉耆質量控制( Quality Control of Hedysarum polybotrys )

Page 11: About OMICS Group

補氣藥

抑制發炎

免疫系統

11

免疫增強

Page 12: About OMICS Group

免疫防禦系統

12

Nonspecific defensesNonspecific defenses(Immune system)

First line of defense Second line of defense Third line of defense

Skin Mucous membranes Secretions of skin

and mucous

membranes

Phagocytic white blood

cells Defensive proteins The inflammatory

response

Lymphocytes Antibodies

The lymphatic system

Page 13: About OMICS Group

晉耆

13

Page 14: About OMICS Group

Immunomodulatory Effects of Astragali Radix Extracts

Immuno-stimulatory Effects

Anti- inflammatory Effects

14

Page 15: About OMICS Group

體外免疫調節實驗模式: In Vitro Splenocyte Model of the

Immuno-modulation Effects Assay

Splenocytes were obtained by gentle disruption of the spleen of BaLb/c female mice and filtration via a 40-m Nylon cell strainer.

The erythrocytes were lysed with 0.38% NH4Cl-Tris buffer (pH 7.4), while the remaining cells were resuspended in RPMI-1640 with 10 mM Hepes, 10% FBS, 100 mg/l streptomycin, and 100 IU/ml penicillin.

Splenocyte Proliferation Assay MTT assay

Natural Killer Cell Activity of Splenocytes in VitroYAC-1 cells were used as the target cells, while splenocytes were the effector cells.LDH assay

Page 16: About OMICS Group

晉耆萃取物刺激脾臟增生作用( Effects of H. polybotrys Extracts on Splenocyte Proliferation )

En

han

ce o

f L

PS

gru

p (

%)

0

20

40

60

80

100

120

140

H M M-H M-EA

100 g/ml

control 0 0.75 1.5 3 (M)

LPS 10 (g/ml)

O.D

.val

ue (6

00 n

m)

0.1

0.2

0.3

0.4

0.5

*

* *

Formononetin

16

Page 17: About OMICS Group

晉耆 M-EA 萃取物使 daunoblastina 誘導的白血球低下症病鼠,白血球提升。( Rise in the WBC of M-EA Treated Daunoblastina-induced Leucopenia mice )

WB

C n

umbe

r (1

03/

l)

0

2

4

6

8

10

Blank Control 100 200M-EA (mg/kg)

*

Blank group: Normal saline i.p. once on day 0, and sterile water orally administered to the mice once a day.Control group: Daunoblastina 20 mg/kg, i.p. once on day 0, and then sterile water orally administered to the mice once a day.Treated group: Daunoblastina 20 mg/kg, i.p. once on day 0, and the M-EA at 100 and 200 mg/kg orally administered to the mice once a day.

17

Page 18: About OMICS Group

Immunomodulatory Effects of Astragali Radix Extracts

Immuno-stimulatory Effects

Anti- inflammatory Effects

18

Page 19: About OMICS Group

發炎介質: Nitric Oxide & PGE2

Tyrosine kinase, NF-κB

L-Citrulline + NOL-Arginine iNOS

COX-2

Inflammation

PGE2

19

Arachidonic acid

LPS, TNF-α, IL-1β, INF-γ

Page 20: About OMICS Group

NO production was detected by Griess reaction

Cytotoxicity was observed by MTT assay

RAW 264.7LPS

NOiNOSTested Samples

Inflammation

PGE2COX-2

iNOS and COX-2 protein expression was detectedby Western blot analysis

PGE2 production was detected by EIA kit

體外抗發炎篩選平台In Vitro, Anti-inflammation-assay Model

20

Page 21: About OMICS Group

0.00

10.00

20.00

30.00

40.00

50.00

60.00

70.00

80.00

90.00

100.00

1 2 3 4 5 6

0.00

0.50

1.00

1.50

2.00

2.50

3.00

NO

MTT

NO

inh

ibit

ion

(%) O

.D. (a

t 60

0 n

m)

B C 25 50 100 200 (mg/ml)B C 25 50 100 200

PG

E2

(pg

/ml)

0

100

200

300

400

500

600

700

M-EA (g/ml)

晉耆 M-EA 萃取物抑制發炎介質作用Anti-inflammation Effects of M-EA

• M-EA extract showed more inhibition on Nitric oxide (NO) production

and PGE2 from LPS-stimulated RAW 264.7 cells than the other

extracts, and the IC50 was 55.75 g/ml. However, the M-EA extract

significantly stimulated proliferation of RAW 264.7 cells.

21

Page 22: About OMICS Group

M-EA extract showed inhibition on iNOS and COX 2 expression from

LPS-stimulated RAW 264.7 cells.

B C 25 50 100 200M-EA (g/ml)

iNOS

COX 2

GAPDH

22

晉耆 M-EA 萃取物抑制 INOS 及 COX-2 蛋白表現作用

Page 23: About OMICS Group

晉耆 M-EA 萃取物可以降低 sodium nitroprusside (SNP) 誘導 RAW 264.7 細胞之細胞毒性

M-EA could significantly prevent cytotoxicity effects from NO-induced RAW

264.7 cells and inhibit NO in a dose dependence manner.

0

0.5

1

1.5

2

2.5

3

0

0.02

0.04

0.06

0.08

0.1

0.12

0.14

0.16

0.18

MTT

NO

O.D

. ( a

t 600

nm

) O.D

. ( at 530 nm

)

SNP (200 M) - + + + +

M-EA (g/ml) - - 25 50 100

**

#####

23

Page 24: About OMICS Group

O.D

. (a

t 6

00

nm

)

0.0

0.1

0.2

0.3

0.4

0.5

* ** ***

SNP 50M - - + + + +

M-EA (g/ml) 0 100 0 25 50 100

*

晉耆 M-EA 萃取物可以降低 sodium nitroprusside (SNP)

誘導脾臟細胞之細胞毒性M-EA could significantly prevent cytotoxicity effects from NO-induced

splenocytes in a dose dependence manner.

24

Page 25: About OMICS Group

小結1. 推測晉耆 M-EA 萃取物,可以透過清除

NO 自由基,而達到刺激脾臟細胞生長之功能。

2. 於白血球低下症之病鼠中,可以加速白血球之提升。

3. 晉耆 M-EA 萃取物,亦可以透過抑制 iNOS

及 COX-2 蛋白表現,而達到降低發炎介質

( NO 及 PGE2 )之功效。

4. 綜合上述,晉耆具有免疫調節之作用。因而推測以黃耆為主藥之黃耆六一湯應具有

免疫調節之功能,繼而進行下列評估。25

Page 26: About OMICS Group

HQLYT 免疫增強作用評估

Splenocyte modeimmuno-modulation

effects l of the assay

Splenocyte Proliferation Assay

Natural Killer Cell Activity

A murine model of cyclophosphamide-

induced leucopenia

26

Page 27: About OMICS Group

YAC-1

T cellB cell

Con-APHA-P LPS

IL-2NK cell

Tc ThIg

IL-2

Splenocytes

Mitogen:

Concanavalin A (ConA)

Phytohaemagglutinin (PHA)

Lipopolysaccharide (LPS)

非特異性免疫反應:脾臟細胞增殖

Page 28: About OMICS Group

O.D

. valu

e (

60

0nm

)

0.2

0.3

0.4

0.5

0.6

control 0 1.56 3.12 6.25 12.5 25 50(g/ml)

PHA: 10 g/ml

O.D

. val

ue (

600n

m)

0.20

0.22

0.24

0.26

0.28

0.30

control 0 3.12 6.25 12.5(g/ml)

Con A: 10 g/ml

O.D

. val

ue (

600n

m)

0.2

0.3

0.4

0.5

0.6

0.7

0.8

control 0 3.1 6.25 12.5 (g/ml)

LPS 10 g/ml

**

*

*

*

*

n=6, *p< 0.05, **p< 0.01

HQLYT 與 LPS 合併處理後,細胞增生比Con A 及 PHA 明顯。

HQLYT 刺激脾臟細胞增生結果

28

Page 29: About OMICS Group

O.D

. va

lue

(6

00

nm

)

0.2

0.3

0.4

0.5

0.6

0.7

0.8

control 0 3.1 6.25 12.5 (g/ml)

LPS 10 g/ml

O.D

. va

lue

(6

00

nm

)

0.0

0.1

0.2

0.3

0.4

0.5

control 0 31.25 62.5 125 250 500 1000 (g/ml)

LPS 10 g/ml

12.78%

O.D

. va

lue

(6

00

nm

)

0.0

0.1

0.2

0.3

control 0 1.9 3.9 7.8 15.6 31.25 62.5 (g/ml)

LPS 10 g/ml

54.6%O

.D. va

lue

(6

00

nm

)

0.0

0.2

0.4

0.6

control 0 1.95 3.9 7.8 15.6 31.25 62.5 (g/ml)

LPS 10 g/ml

87.8%

HQLYT39%

**

* **

*

***

Radix Astragali Licorice

Jujube

29

Page 30: About OMICS Group

HQLYT more-strongly stimulated the proliferation effects of splenocytes than did Radix Astragali, licorice, and jujube used individually.

Enhanced proliferation percentage of splenocytes (%)

μg/ml 12.5 3.9 7.5

HQLYT 87.8

AR (黃耆) 0 0

GR (甘草) 38.0 54.6

ZF (大棗) 17.3 24.7

Total 55.3 79.3

AR, Radix Astragali; GR, licorice; ZF, jujube.

30

Page 31: About OMICS Group

體外脾臟細胞中自然殺手細胞活性: Natural Killer Cell

Activity of Splenocytes in Vitro

加入 NK 細胞至標地細胞YAC-1 細胞標定放射性物質 NK 細胞殺死標地細胞

測量細胞外之放射線量

12 : 1 25 : 1 50 : 1

Cyt

otox

icity

aga

inst

YA

C-1

cel

l (%

)

0

20

40

60

80

100

120

YAC-1 cells were used as the target cells, while splenocytes were the effector cells. Cytotoxic activity against YAC-1 cells was measured by the lactate dehydrogenase (LDH) release assay.

31

Page 32: About OMICS Group

體內免疫調節實驗模式

The whole blood of hearts and spleens were obtained from BaLb/c mice killed by cervical dislocation under sterile conditions.

Serum of whole blood

The IL-2 Assay Natural Killer Cell Activity Assay

HQLYT was orally administered to BaLb/c mice once a day for 14 days

32

Splenocytes

Page 33: About OMICS Group

HQLYT 對 BaLb/c 小鼠之 IL-2 分泌影響 Effects of HQLYT on the IL-2 Assay in BaLb/c Mice

The amount of IL-2 in HQLYT-treated BaLb/c mice was higher than in the control group at 400, 800, and 1600 mg/kg but there was no significant dose dependence.

control 400 800 1600 (mg/kg)

IL-2

(

pg

/ml)

0

20

40

60

80

100

120

140

Each group contained three mice.

33

Page 34: About OMICS Group

HQLYT 對 BaLb/c 小鼠之自然殺手細胞之影響 Effects of HQLYT on Natural Killer Cell Activity of Splenocytes in Vivo

The effector cells (splenocytes from 400 mg/kg HQLYT-treated BaLb/c mice) were reacted with target cells (YAC-1). The cytotoxic activity of NK cells was enhanced by more than 50% at the ratios of the effector and target of 15:1, 20:1, and 25:1.

15 : 1 20 : 1 25 : 1

Cyt

oto

xici

ty a

gai

nst

YA

C-1

cel

l (%

)

0

20

40

60

80

100

YAC-1 cells were used as the target cells, while splenocytes were the effector cells.Cytotoxic activity against YAC-1 cells was measured by the lactate dehydrogenase (LDH) release assay.

Page 35: About OMICS Group

Cyclophosphamide 誘導小鼠白血球低下症實驗模式: Murine Model of Cyclophosphamide-induced Leucopenia

0 1 2 3 4 5 6

WB

C c

ou

nt (1

03 /

l)

1.5

2.0

2.5

3.0

3.5

4.0

4.5

5.0

controlinduced

Days

BaLb/c mice were injected intraperitoneally (i.p.) with 100 mg cyclophosphamide /kg BW was administered once on day 0, and then 400 mg of HQLYT /kg BW was orally administered to mice once a day for 6 days in the treated group.

The white blood cells (WBC) levels of the whole blood were analyzed by an automatic multi-parameter blood cell counter (Sysmex KX-21N).

35

Whole blood was obtained from an eyehole vein of BaLb/c mice before treatment with HQLYT every day.

Page 36: About OMICS Group

HQLYT 使白血球低下症之小鼠的白血球顯著上升

WBC count (103/μl) Blank group Induced group Treated group

P value

0 day 3.89 ± 1.33

1st day 2.54 ± 0.65 2.02 ± 0.30 3.74 ± 1.22 **

2nd day 4.48 ± 0.68 2.04 ± 0.15 3.22 ± 1.39 **

3rd day 3.06 ± 0.53 2.08 ± 0.36 2.82 ± 1.03

4th day 4.00 ± 1.02 2.32 ± 0.25 3.76 ± 1.69 **

5th day 4.38 ± 1.09 2.64 ± 0.19 3.93 ± 0.60 **

Blank group: Normal saline i.p. once on day 0, and sterile water orally administered to the mice once a day for 6 days.Induced group: Cyclophosphamide 100 mg/kg, i.p. once on day 0, and then sterile water orally administered to the mice once a day for 6 days.Treated group: Cyclophosphamide 100 mg/kg, i.p. once on day 0, and the HQLYT at 400 mg/kg orally administered to the mice once a day for 6 days.Each group contained five mice. MANOVA, **p < 0.01.

36

Page 37: About OMICS Group

總結• 黃耆六一湯可以預防 daunorubicin 誘導之毒性,並增強

daunorubicin 的抗癌作用,延長 P388-CDF1 擔癌鼠之存活率。

• 黃耆六一湯透過刺激 IL-2 釋放,活化 NK 細胞,及提升白血球水平,而達到輔助抗癌藥功效。

• 本研究之黃耆六一湯主藥材使用晉耆,具有免疫調節功能,其指標活性成分建議可以用 formononetin 。

• 綜合之,黃耆六一湯適合作為日常免疫提升之滋補湯劑。

37

Page 38: About OMICS Group

38

We are family…We happily work together, because we have the same dream.

Page 39: About OMICS Group

Lets Meet again at Pharmacognosy-2015

3rd International Conference and Exhibition on Pharmacognosy, Phytochemistry and Natural

ProductsOctober 26-28, 2015 Hyderabad, India

Theme: Advanced trends for the future of Herbal Drugs and Products

Website: http://pharmacognosy-phytochemistry-natural-products.pharmaceuticalconferences.com/